In the 2017 classification, clEDS was exclusively linked to pathogenic variants in TNXB; after the identification of AEBP1- clEDS, the condition is also denoted as clEDS type 1. This evidence concerns the gene TNXB and Ehlers-Danlos syndrome due to tenascin-X deficiency.